✦ LIBER ✦

Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients

✍ Scribed by A. Bruchfeld; K. Lindahl; O. Reichard; T. Carlsson; R. Schvarcz

Book ID: 108885839
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 59 KB
Volume: 13
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2005.00680.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic hepatitis C: Treatment of pegyla

Chronic hepatitis C: Treatment of pegylated interferon/ ribavirin nonresponders

✍ Mitchell L. Shiffman 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 178 KB

Chronic hepatitis C: Treatment of pegyla

Chronic hepatitis C: Treatment of pegylated interferon/ ribavirin nonresponders

✍ Mitchell L. Shiffman 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 177 KB

Treatment of chronic hepatitis C with PE

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin

✍ Markus Cornberg; Heiner Wedemeyer; Michael P. Manns 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 513 KB

Leukocyte interferon-α and ribavirin for

Leukocyte interferon-α and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon

✍ Luigi E. Adinolfi; Emanuele Durante-Mangoni; Marta Salzillo; Aldo Marrone; Marie 📂 Article 📅 2009 🏛 Springer Milan 🌐 English ⚖ 161 KB

Merimepodib, pegylated interferon, and r

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

✍ Vinod K. Rustgi; William M. Lee; Eric Lawitz; Stuart C. Gordon; Nezam Afdhal; Fr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

on behalf of the MErimepodib TRiple cOmbination (METRO) study group Merimepodib (MMPD) is an orally administered, inosine monophosphate dehydrogenase inhibitor that has shown antiviral activity in nonresponders with chronic hepatitis C (CHC) when combined with pegylated interferon alfa 2a (Peg-IFN-a

Hepatitis C patients’ self-reported adhe

Hepatitis C patients’ self-reported adherence to treatment with pegylated interferon and ribavirin

✍ J. J. WEISS; L. BHATTI; D. T. DIETERICH; B. R. EDLIN; D. A. FISHBEIN; M. B. GOET 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB